VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q16735186 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000150.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q16735186‏
024 ‎‡a 0000-0002-2397-0443‏ ‎‡2 orcid‏
024 ‎‡a 57034598400‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q16735186‏
043 ‎‡c US‏
046 ‎‡s 19000000‏
100 0 ‎‡a Richard Lee‏ ‎‡c American cardiac surgeon (21st century)‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a ريتشارد لي‏ ‎‡c جراح من الولايات المتحدة الأمريكية‏ ‎‡9 ar‏
400 0 ‎‡a Richard Lee‏ ‎‡c siruhano Merikano‏ ‎‡9 pap‏
400 0 ‎‡a Ричард Ли‏ ‎‡9 ru‏
400 0 ‎‡a Richard Lee (Cardiac Surgeon)‏ ‎‡c Amerikaans chirurg‏ ‎‡9 nl‏
400 0 ‎‡a Richard Lee‏ ‎‡c chirurgien américain (21e siècle)‏ ‎‡9 fr‏
400 0 ‎‡a Richard Lee‏ ‎‡c ciruxanu estauxunidense‏ ‎‡9 ast‏
400 0 ‎‡a রিচার্ড লি‏ ‎‡9 bn‏
400 0 ‎‡a Richard Lee‏ ‎‡c amerikanischer Chirurg (21. Jahrhundert)‏ ‎‡9 de‏
400 0 ‎‡a ریچارد لی‏ ‎‡9 fa‏
670 ‎‡a Author's A Fluorescent Probe for Detecting Mycobacterium tuberculosis and Identifying Genes Critical for Cell Entry‏
670 ‎‡a Author's A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents‏
670 ‎‡a Author's A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin‏
670 ‎‡a Author's A pantothenate kinase from Staphylococcus aureus refractory to feedback regulation by coenzyme A.‏
670 ‎‡a Author's A screen for and validation of prodrug antimicrobials‏
670 ‎‡a Author's A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria‏
670 ‎‡a Author's A statistical framework to evaluate virtual screening‏
670 ‎‡a Author's A therapeutic approach to pantothenate kinase associated neurodegeneration‏
670 ‎‡a Author's Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria‏
670 ‎‡a Author's Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites‏
670 ‎‡a Author's Acyl-Phosphates Initiate Membrane Phospholipid Synthesis in Gram-Positive Pathogens‏
670 ‎‡a Author's Acyl-sulfamates target the essential glycerol-phosphate acyltransferase (PlsY) in Gram-positive bacteria‏
670 ‎‡a Author's Allosteric Regulation of Mammalian Pantothenate Kinase‏
670 ‎‡a Author's Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens‏
670 ‎‡a Author's Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections‏
670 ‎‡a Author's Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone‏
670 ‎‡a Author's Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs‏
670 ‎‡a Author's Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties‏
670 ‎‡a Author's Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives‏
670 ‎‡a Author's Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs‏
670 ‎‡a Author's Catalysis and Sulfa Drug Resistance in Dihydropteroate Synthase‏
670 ‎‡a Author's Characterization of the in vitro synthesized arabinan of mycobacterial cell walls‏
670 ‎‡a Author's Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis‏
670 ‎‡a Author's Chemical modulation of the biological activity of reutericyclin: a membrane-active antibiotic from Lactobacillus reuteri‏
670 ‎‡a Author's Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates‏
670 ‎‡a Author's Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice‏
670 ‎‡a Author's Covalent modification of the Mycobacterium tuberculosis FAS-II dehydratase by Isoxyl and Thiacetazone‏
670 ‎‡a Author's Crystal Structure of the 6-Hydroxymethyl-7,8-Dihydropterin Pyrophosphokinase•Dihydropteroate Synthase Bifunctional Enzyme from Francisella tularensis‏
670 ‎‡a Author's Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase‏
670 ‎‡a Author's Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties‏
670 ‎‡a Author's Design, synthesis, and evaluation of novel ethambutol analogues‏
670 ‎‡a Author's Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics‏
670 ‎‡a Author's Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue‏
670 ‎‡a Author's Development of a pterin-based fluorescent probe for screening dihydropteroate synthase‏
670 ‎‡a Author's Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy.‏
670 ‎‡a Author's Development of BODIPY FL Thalidomide As a High-Affinity Fluorescent Probe for Cereblon in a Time-Resolved Fluorescence Resonance Energy Transfer Assay‏
670 ‎‡a Author's Development of BODIPY FL vindoline as a novel and high-affinity pregnane X receptor fluorescent probe‏
670 ‎‡a Author's Discovery and Characterization of the Antimetabolite Action of Thioacetamide-Linked 1,2,3-Triazoles as Disruptors of Cysteine Biosynthesis in Gram-Negative Bacteria‏
670 ‎‡a Author's Discovery of non-carbohydrate inhibitors of aminoglycoside-modifying enzymes‏
670 ‎‡a Author's Discovery of novel bacterial elongation condensing enzyme inhibitors by virtual screening‏
670 ‎‡a Author's Discovery of novel isoxazolines as anti-tuberculosis agents‏
670 ‎‡a Author's Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity‏
670 ‎‡a Author's Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity‏
670 ‎‡a Author's Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections‏
670 ‎‡a Author's Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead‏
670 ‎‡a Author's Exposure of Methicillin-Resistant Staphylococcus aureus to Low Levels of the Antibacterial THAM-3ΦG Generates a Small Colony Drug-Resistant Phenotype.‏
670 ‎‡a Author's First cultivation and characterization of Mycobacterium ulcerans from the environment‏
670 ‎‡a Author's Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection‏
670 ‎‡a Author's Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans‏
670 ‎‡a Author's Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans‏
670 ‎‡a Author's Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F‏
670 ‎‡a Author's Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence‏
670 ‎‡a Author's Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase‏
670 ‎‡a Author's Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis‏
670 ‎‡a Author's In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori‏
670 ‎‡a Author's In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics‏
670 ‎‡a Author's In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB‏
670 ‎‡a Author's Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane‏
670 ‎‡a Author's Inhibition of UDP-Gal Mutase and Mycobacterial Galactan Biosynthesis by Pyrrolidine Analogues of Galactofuranose‏
670 ‎‡a Author's Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.‏
670 ‎‡a Author's LipE guided discovery of isopropylphenyl pyridazines as pantothenate kinase modulators‏
670 ‎‡a Author's Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium‏
670 ‎‡a Author's Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in Mycobacterium tuberculosis‏
670 ‎‡a Author's Metabolic activation of CaMKII by coenzyme A.‏
670 ‎‡a Author's Methods for acquisition and assignment of multidimensional high-resolution magic angle spinning NMR of whole cell bacteria‏
670 ‎‡a Author's Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis‏
670 ‎‡a Author's Mycobacterial arabinan biosynthesis: the use of synthetic arabinoside acceptors in the development of an arabinosyl transfer assay‏
670 ‎‡a Author's Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence‏
670 ‎‡a Author's Mycolic acid biosynthesis: definition and targeting of the Claisen condensation step‏
670 ‎‡a Author's Mycolic acids: structure, biosynthesis and physiological functions‏
670 ‎‡a Author's N-substituted 3-acetyltetramic acid derivatives as antibacterial agents‏
670 ‎‡a Author's New agents for the treatment of drug-resistant Mycobacterium tuberculosis‏
670 ‎‡a Author's Nitrofurans as novel anti-tuberculosis agents: identification, development and evaluation‏
670 ‎‡a Author's Novel acyl phosphate mimics that target PlsY, an essential acyltransferase in gram-positive bacteria‏
670 ‎‡a Author's Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis‏
670 ‎‡a Author's Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis‏
670 ‎‡a Author's Novel Polyoxyethylene-Containing Glycolipids Are Synthesized in Corynebacterium matruchotii and Mycobacterium smegmatis Cultured in the Presence of Tween 80.‏
670 ‎‡a Author's Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated‏
670 ‎‡a Author's Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant trypanosomes‏
670 ‎‡a Author's Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis‏
670 ‎‡a Author's Pharmacokinetically-guided lead optimization of nitrofuranylamide anti-tuberculosis agents‏
670 ‎‡a Author's Phase II Metabolic Pathways of Spectinamide Antitubercular Agents: A Comparative Study of the Reactivity of 4-Substituted Pyridines to Glutathione Conjugation‏
670 ‎‡a Author's Potentiation of azole antifungals by 2-adamantanamine‏
670 ‎‡a Author's Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents‏
670 ‎‡a Author's Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents‏
670 ‎‡a Author's Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed‏
670 ‎‡a Author's RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host‏
670 ‎‡a Author's Replacing sulfa drugs with novel DHPS inhibitors‏
670 ‎‡a Author's Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations‏
670 ‎‡a Author's SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A‏
670 ‎‡a Author's Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability‏
670 ‎‡a Author's Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library‏
670 ‎‡a Author's Solid-phase synthesis of a thymidinyl dipeptide urea library‏
670 ‎‡a Author's Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux‏
670 ‎‡a Author's Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models‏
670 ‎‡a Author's Structural and In Vivo Studies on Trehalose-6-Phosphate Synthase from Pathogenic Fungi Provide Insights into Its Catalytic Mechanism, Biological Necessity, and Potential for Novel Antifungal Drug Design‏
670 ‎‡a Author's Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases‏
670 ‎‡a Author's Structural Characterization of the Mycobacterium tuberculosis Biotin Biosynthesis Enzymes 7,8-Diaminopelargonic Acid Synthase and Dethiobiotin Synthetase,‏
670 ‎‡a Author's Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase‏
670 ‎‡a Author's Structure-activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors‏
670 ‎‡a Author's Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions‏
670 ‎‡a Author's Structure-Based Design of Novel Pyrimido[4,5-c]pyridazine Derivatives as Dihydropteroate Synthase Inhibitors with Increased Affinity‏
670 ‎‡a Author's Structure-Based Design, Synthesis, and Evaluation of 2′-(2-Hydroxyethyl)-2′-deoxyadenosine and the 5′-Diphosphate Derivative as Ribonucleotide Reductase Inhibitors‏
670 ‎‡a Author's Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agents‏
670 ‎‡a Author's Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents‏
670 ‎‡a Author's Synthesis and evaluation of esters and carbamates to identify critical functional groups for esterase-specific metabolism‏
670 ‎‡a Author's Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents‏
670 ‎‡a Author's Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids‏
670 ‎‡a Author's Synthesis and Evaluation of Thiazolidine Amide and N-Thiazolyl Amide Fluoroquinolone Derivatives.‏
670 ‎‡a Author's Synthesis and Structure–Activity Relationship of Thioacetamide-Triazoles against Escherichia coli‏
670 ‎‡a Author's Synthesis and structure of mycolactone E isolated from frog mycobacterium‏
670 ‎‡a Author's Synthesis of beta-D-arabinofuranosyl-1-monophosphoryl polyprenols: examination of their function as mycobacterial arabinosyl transferase donors.‏
670 ‎‡a Author's Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes‏
670 ‎‡a Author's Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-‏
670 ‎‡a Author's Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability‏
670 ‎‡a Author's Synthesis, optimization and structure-activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents‏
670 ‎‡a Author's Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives‏
670 ‎‡a Author's Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections‏
670 ‎‡a Author's The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase‏
670 ‎‡a Author's The membrane as a target for controlling hypervirulent Clostridium difficile infections‏
670 ‎‡a Author's The structure-activity relationship of urea derivatives as anti-tuberculosis agents‏
670 ‎‡a Author's The structure of the pantothenate kinase.ADP.pantothenate ternary complex reveals the relationship between the binding sites for substrate, allosteric regulator, and antimetabolites‏
670 ‎‡a Author's Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3‏
670 ‎‡a Author's Topology and Active Site of PlsY‏
670 ‎‡a Author's Ureadepsipeptides as ClpP Activators‏
670 ‎‡a Author's Validation of molecular docking programs for virtual screening against dihydropteroate synthase‏
670 ‎‡a wikidata site links‏ ‎‡u https://en.wikipedia.org/wiki/Richard_Lee_(surgeon)‏
909 ‎‡a (orcid) 0000000223970443‏ ‎‡9 1‏
909 ‎‡a (scopus) 57034598400‏ ‎‡9 1‏
919 ‎‡a fluorescentprobefordetectingmycobacteriumtuberculosisandidentifyinggenescriticalforcellentry‏ ‎‡A A Fluorescent Probe for Detecting Mycobacterium tuberculosis and Identifying Genes Critical for Cell Entry‏ ‎‡9 1‏
919 ‎‡a microbiologicalassessmentofnovelnitrofuranylamidesasantituberculosisagents‏ ‎‡A A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents‏ ‎‡9 1‏
919 ‎‡a newlydiscoveredmycobacterialpathogenisolatedfromlaboratorycoloniesofxenopusspecieswithlethalinfectionsproducesanovelformofmycolactonethemycobacteriumulceransmacrolidetoxin‏ ‎‡A A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin‏ ‎‡9 1‏
919 ‎‡a pantothenatekinasefromstaphylococcusaureusrefractorytofeedbackregulationbycoenzymea‏ ‎‡A A pantothenate kinase from Staphylococcus aureus refractory to feedback regulation by coenzyme A.‏ ‎‡9 1‏
919 ‎‡a screenforandvalidationofprodrugantimicrobials‏ ‎‡A A screen for and validation of prodrug antimicrobials‏ ‎‡9 1‏
919 ‎‡a simpleinvitropkpdmodelsystemtodeterminetimekillcurvesofdrugsagainstmycobacteria‏ ‎‡A A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria‏ ‎‡9 1‏
919 ‎‡a statisticalframeworktoevaluatevirtualscreening‏ ‎‡A A statistical framework to evaluate virtual screening‏ ‎‡9 1‏
919 ‎‡a therapeuticapproachtopantothenatekinaseassociatedneurodegeneration‏ ‎‡A A therapeutic approach to pantothenate kinase associated neurodegeneration‏ ‎‡9 1‏
919 ‎‡a activationofexogenousfattyacidstoacylacylcarrierproteincannotbypassfabiinhibitioninneisseria‏ ‎‡A Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria‏ ‎‡9 1‏
919 ‎‡a acylcarrierproteinisacellulartargetfortheantibacterialactionofthepantothenamideclassofpantothenateantimetabolites‏ ‎‡A Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites‏ ‎‡9 1‏
919 ‎‡a acylphosphatesinitiatemembranephospholipidsynthesisingrampositivepathogens‏ ‎‡A Acyl-Phosphates Initiate Membrane Phospholipid Synthesis in Gram-Positive Pathogens‏ ‎‡9 1‏
919 ‎‡a acylsulfamatestargettheessentialglycerolphosphateacyltransferaseplsyingrampositivebacteria‏ ‎‡A Acyl-sulfamates target the essential glycerol-phosphate acyltransferase (PlsY) in Gram-positive bacteria‏ ‎‡9 1‏
919 ‎‡a allostericregulationofmammalianpantothenatekinase‏ ‎‡A Allosteric Regulation of Mammalian Pantothenate Kinase‏ ‎‡9 1‏
919 ‎‡a aminomethylspectinomycinsanovelantibacterialchemotypeforbiothreatpathogens‏ ‎‡A Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens‏ ‎‡9 1‏
919 ‎‡a aminomethylspectinomycinsastherapeuticsfordrugresistantrespiratorytractandsexuallytransmittedbacterialinfections‏ ‎‡A Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections‏ ‎‡9 1‏
919 ‎‡a analysisofmycobacteriumspeciesforthepresenceofamacrolidetoxinmycolactone‏ ‎‡A Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone‏ ‎‡9 1‏
919 ‎‡a antibacterialandantitubercularactivityoffosmidomycinfr900098andtheirlipophilicanalogs‏ ‎‡A Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs‏ ‎‡9 1‏
919 ‎‡a antitubercularnitrofuranisoxazolineswithimprovedpharmacokineticproperties‏ ‎‡A Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties‏ ‎‡9 1‏
919 ‎‡a applicationsofpharmacometricsintheclinicaldevelopmentandpharmacotherapyofantiinfectives‏ ‎‡A Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives‏ ‎‡9 1‏
919 ‎‡a biopharmaceuticspharmacokineticsandpharmacodynamicsofantituberculosisdrugs‏ ‎‡A Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs‏ ‎‡9 1‏
919 ‎‡a catalysisandsulfadrugresistanceindihydropteroatesynthase‏ ‎‡A Catalysis and Sulfa Drug Resistance in Dihydropteroate Synthase‏ ‎‡9 1‏
919 ‎‡a characterizationoftheinvitrosynthesizedarabinanofmycobacterialcellwalls‏ ‎‡A Characterization of the in vitro synthesized arabinan of mycobacterial cell walls‏ ‎‡9 1‏
919 ‎‡a chemicalknockoutofpantothenatekinaserevealsthemetabolicandgeneticprogramresponsibleforhepaticcoenzymeahomeostasis‏ ‎‡A Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis‏ ‎‡9 1‏
919 ‎‡a chemicalmodulationofthebiologicalactivityofreutericyclinamembraneactiveantibioticfromlactobacillusreuteri‏ ‎‡A Chemical modulation of the biological activity of reutericyclin: a membrane-active antibiotic from Lactobacillus reuteri‏ ‎‡9 1‏
919 ‎‡a combinatorialleadoptimizationofdiaminesbasedonethambutolaspotentialantituberculosispreclinicalcandidates‏ ‎‡A Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates‏ ‎‡9 1‏
919 ‎‡a comparativepharmacokineticsofspectinamide1599aftersubcutaneousandintrapulmonaryaerosoladministrationinmice‏ ‎‡A Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice‏ ‎‡9 1‏
919 ‎‡a covalentmodificationofthemycobacteriumtuberculosisfas2dehydratasebyisoxylandthiacetazone‏ ‎‡A Covalent modification of the Mycobacterium tuberculosis FAS-II dehydratase by Isoxyl and Thiacetazone‏ ‎‡9 1‏
919 ‎‡a crystalstructureofthe6hydroxymethyl78dihydropterinpyrophosphokinasedihydropteroatesynthasebifunctionalenzymefromfrancisellatularensis‏ ‎‡A Crystal Structure of the 6-Hydroxymethyl-7,8-Dihydropterin Pyrophosphokinase•Dihydropteroate Synthase Bifunctional Enzyme from Francisella tularensis‏ ‎‡9 1‏
919 ‎‡a crystalstructureoftheanthraxdrugtargetbacillusanthracisdihydrofolatereductase‏ ‎‡A Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase‏ ‎‡9 1‏
919 ‎‡a designsynthesisandantituberculosisactivityof1adamantyl3heteroarylureaswithimprovedinvitropharmacokineticproperties‏ ‎‡A Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties‏ ‎‡9 1‏
919 ‎‡a designsynthesisandevaluationofnovelethambutolanalogues‏ ‎‡A Design, synthesis, and evaluation of novel ethambutol analogues‏ ‎‡9 1‏
919 ‎‡a designsynthesisandmicrobiologicalevaluationofampicillintetramicacidhybridantibiotics‏ ‎‡A Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics‏ ‎‡9 1‏
919 ‎‡a detectionofmycolactoneabinmycobacteriumulceransinfectedhumantissue‏ ‎‡A Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue‏ ‎‡9 1‏
919 ‎‡a developmentofapterinbasedfluorescentprobeforscreeningdihydropteroatesynthase‏ ‎‡A Development of a pterin-based fluorescent probe for screening dihydropteroate synthase‏ ‎‡9 1‏
919 ‎‡a developmentofanetoposideprodrugfordualprodrugenzymeantitumortherapy‏ ‎‡A Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy.‏ ‎‡9 1‏
919 ‎‡a developmentofbodipyflthalidomideasahighaffinityfluorescentprobeforcerebloninatimeresolvedfluorescenceresonanceenergytransferassay‏ ‎‡A Development of BODIPY FL Thalidomide As a High-Affinity Fluorescent Probe for Cereblon in a Time-Resolved Fluorescence Resonance Energy Transfer Assay‏ ‎‡9 1‏
919 ‎‡a developmentofbodipyflvindolineasanovelandhighaffinitypregnane10receptorfluorescentprobe‏ ‎‡A Development of BODIPY FL vindoline as a novel and high-affinity pregnane X receptor fluorescent probe‏ ‎‡9 1‏
919 ‎‡a discoveryandcharacterizationoftheantimetaboliteactionofthioacetamidelinked123triazolesasdisruptorsofcysteinebiosynthesisingramnegativebacteria‏ ‎‡A Discovery and Characterization of the Antimetabolite Action of Thioacetamide-Linked 1,2,3-Triazoles as Disruptors of Cysteine Biosynthesis in Gram-Negative Bacteria‏ ‎‡9 1‏
919 ‎‡a discoveryofnoncarbohydrateinhibitorsofaminoglycosidemodifyingenzymes‏ ‎‡A Discovery of non-carbohydrate inhibitors of aminoglycoside-modifying enzymes‏ ‎‡9 1‏
919 ‎‡a discoveryofnovelbacterialelongationcondensingenzymeinhibitorsbyvirtualscreening‏ ‎‡A Discovery of novel bacterial elongation condensing enzyme inhibitors by virtual screening‏ ‎‡9 1‏
919 ‎‡a discoveryofnovelisoxazolinesasantituberculosisagents‏ ‎‡A Discovery of novel isoxazolines as anti-tuberculosis agents‏ ‎‡9 1‏
919 ‎‡a discoveryofnovelselectiveinhibitorsofhumanintestinalcarboxylesterasefortheameliorationofirinotecaninduceddiarrheasynthesisquantitativestructureactivityrelationshipanalysisandbiologicalactivity‏ ‎‡A Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity‏ ‎‡9 1‏
919 ‎‡a discoverysynthesisandbiologicalevaluationofpiperidinolanalogswithantituberculosisactivity‏ ‎‡A Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity‏ ‎‡9 1‏
919 ‎‡a evaluationofanalogsofreutericyclinasprospectivecandidatesfortreatmentofstaphylococcalskininfections‏ ‎‡A Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections‏ ‎‡9 1‏
919 ‎‡a evaluationofflavonoidandresveratrolchemicallibrariesrevealsabyssinone2asapromisingantibacteriallead‏ ‎‡A Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead‏ ‎‡9 1‏
919 ‎‡a exposureofmethicillinresistantstaphylococcusaureustolowlevelsoftheantibacterialtham3φggeneratesasmallcolonydrugresistantphenotype‏ ‎‡A Exposure of Methicillin-Resistant Staphylococcus aureus to Low Levels of the Antibacterial THAM-3ΦG Generates a Small Colony Drug-Resistant Phenotype.‏ ‎‡9 1‏
919 ‎‡a 1cultivationandcharacterizationofmycobacteriumulceransfromtheenvironment‏ ‎‡A First cultivation and characterization of Mycobacterium ulcerans from the environment‏ ‎‡9 1‏
919 ‎‡a gastrointestinallocalizationofmetronidazolebyalactobacilliinspiredtetramicacidmotifimprovestreatmentoutcomesinthehamstermodelofclostridiumdifficileinfection‏ ‎‡A Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection‏ ‎‡9 1‏
919 ‎‡a genomewideexpressionprofilingoftheresponsetociclopiroxolamineincandidaalbicans‏ ‎‡A Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans‏ ‎‡9 1‏
919 ‎‡a giantplasmidencodedpolyketidesynthasesproducethemacrolidetoxinofmycobacteriumulcerans‏ ‎‡A Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans‏ ‎‡9 1‏
919 ‎‡a globallydistributedmycobacterialfishpathogensproduceanovelplasmidencodedtoxicmacrolidemycolactonef‏ ‎‡A Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F‏ ‎‡9 1‏
919 ‎‡a heterogeneityofmycolactonesproducedbyclinicalisolatesofmycobacteriumulceransimplicationsforvirulence‏ ‎‡A Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence‏ ‎‡9 1‏
919 ‎‡a identificationandcharacterizationofanallostericinhibitorysiteondihydropteroatesynthase‏ ‎‡A Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase‏ ‎‡9 1‏
919 ‎‡a identificationofageneinvolvedinthebiosynthesisofcyclopropanatedmycolicacidsinmycobacteriumtuberculosis‏ ‎‡A Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis‏ ‎‡9 1‏
919 ‎‡a invitroandinvivoactivitiesofhpi1aselectiveantimicrobialagainsthelicobacterpylori‏ ‎‡A In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori‏ ‎‡9 1‏
919 ‎‡a invitroandinvivoevaluationofsynergismbetweenantitubercularspectinamidesandnonclassicaltuberculosisantibiotics‏ ‎‡A In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics‏ ‎‡9 1‏
919 ‎‡a invitropharmacokineticpharmacodynamicmodelsinantiinfectivedrugdevelopmentfocusontb‏ ‎‡A In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB‏ ‎‡9 1‏
919 ‎‡a inhibitionofmycolicacidtransportacrossthemycobacteriumtuberculosisplasmamembrane‏ ‎‡A Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane‏ ‎‡9 1‏
919 ‎‡a inhibitionofudpgalmutaseandmycobacterialgalactanbiosynthesisbypyrrolidineanaloguesofgalactofuranose‏ ‎‡A Inhibition of UDP-Gal Mutase and Mycobacterial Galactan Biosynthesis by Pyrrolidine Analogues of Galactofuranose‏ ‎‡9 1‏
919 ‎‡a isoniazidaffectsmultiplecomponentsofthetype2fattyacidsynthasesystemofmycobacteriumtuberculosis‏ ‎‡A Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.‏ ‎‡9 1‏
919 ‎‡a lipeguideddiscoveryofisopropylphenylpyridazinesaspantothenatekinasemodulators‏ ‎‡A LipE guided discovery of isopropylphenyl pyridazines as pantothenate kinase modulators‏ ‎‡9 1‏
919 ‎‡a mechanismsinvolvedintheintrinsicisoniazidresistanceofmycobacteriumavium‏ ‎‡A Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium‏ ‎‡9 1‏
919 ‎‡a mechanismsofresistanceassociatedwiththeinhibitionofthedehydrationstepoftype2fattyacidsynthaseinmycobacteriumtuberculosis‏ ‎‡A Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in Mycobacterium tuberculosis‏ ‎‡9 1‏
919 ‎‡a metabolicactivationofcamkiibycoenzymea‏ ‎‡A Metabolic activation of CaMKII by coenzyme A.‏ ‎‡9 1‏
919 ‎‡a methodsforacquisitionandassignmentofmultidimensionalhighresolutionmagicanglespinningnmrofwholecellbacteria‏ ‎‡A Methods for acquisition and assignment of multidimensional high-resolution magic angle spinning NMR of whole cell bacteria‏ ‎‡9 1‏
919 ‎‡a modelbasedexposureresponseassessmentforspectinamide1810inamousemodeloftuberculosis‏ ‎‡A Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis‏ ‎‡9 1‏
919 ‎‡a mycobacterialarabinanbiosynthesistheuseofsyntheticarabinosideacceptorsinthedevelopmentofanarabinosyltransferassay‏ ‎‡A Mycobacterial arabinan biosynthesis: the use of synthetic arabinoside acceptors in the development of an arabinosyl transfer assay‏ ‎‡9 1‏
919 ‎‡a mycolactoneapolyketidetoxinfrommycobacteriumulceransrequiredforvirulence‏ ‎‡A Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence‏ ‎‡9 1‏
919 ‎‡a mycolicacidbiosynthesisdefinitionandtargetingoftheclaisencondensationstep‏ ‎‡A Mycolic acid biosynthesis: definition and targeting of the Claisen condensation step‏ ‎‡9 1‏
919 ‎‡a mycolicacidsstructurebiosynthesisandphysiologicalfunctions‏ ‎‡A Mycolic acids: structure, biosynthesis and physiological functions‏ ‎‡9 1‏
919 ‎‡a nsubstituted3acetyltetramicacidderivativesasantibacterialagents‏ ‎‡A N-substituted 3-acetyltetramic acid derivatives as antibacterial agents‏ ‎‡9 1‏
919 ‎‡a newagentsforthetreatmentofdrugresistantmycobacteriumtuberculosis‏ ‎‡A New agents for the treatment of drug-resistant Mycobacterium tuberculosis‏ ‎‡9 1‏
919 ‎‡a nitrofuransasnovelantituberculosisagentsidentificationdevelopmentandevaluation‏ ‎‡A Nitrofurans as novel anti-tuberculosis agents: identification, development and evaluation‏ ‎‡9 1‏
919 ‎‡a novelacylphosphatemimicsthattargetplsyanessentialacyltransferaseingrampositivebacteria‏ ‎‡A Novel acyl phosphate mimics that target PlsY, an essential acyltransferase in gram-positive bacteria‏ ‎‡9 1‏
919 ‎‡a novelinhibitorsofanemergingtargetinmycobacteriumtuberculosissubstitutedthiazolidinonesasinhibitorsofdtdprhamnosesynthesis‏ ‎‡A Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis‏ ‎‡9 1‏
919 ‎‡a novelinsightsintothemechanismofinhibitionofmmpl3atargetofmultiplepharmacophoresinmycobacteriumtuberculosis‏ ‎‡A Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis‏ ‎‡9 1‏
919 ‎‡a novelpolyoxyethylenecontainingglycolipidsaresynthesizedincorynebacteriummatruchotiiandmycobacteriumsmegmatisculturedinthepresenceoftween80‏ ‎‡A Novel Polyoxyethylene-Containing Glycolipids Are Synthesized in Corynebacterium matruchotii and Mycobacterium smegmatis Cultured in the Presence of Tween 80.‏ ‎‡9 1‏
919 ‎‡a pantothenamidesarepotentontargetinhibitorsofplasmodiumfalciparumgrowthwhenserumpantetheinaseisinactivated‏ ‎‡A Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated‏ ‎‡9 1‏
919 ‎‡a pentacyclicnitrofuransthatrapidlykillnifurtimoxresistanttrypanosomes‏ ‎‡A Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant trypanosomes‏ ‎‡9 1‏
919 ‎‡a pentacyclicnitrofuranswithinvivoefficacyandactivityagainstnonreplicatingmycobacteriumtuberculosis‏ ‎‡A Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis‏ ‎‡9 1‏
919 ‎‡a pharmacokineticallyguidedleadoptimizationofnitrofuranylamideantituberculosisagents‏ ‎‡A Pharmacokinetically-guided lead optimization of nitrofuranylamide anti-tuberculosis agents‏ ‎‡9 1‏
919 ‎‡a phase2metabolicpathwaysofspectinamideantitubercularagentsacomparativestudyofthereactivityof4substitutedpyridinestoglutathioneconjugation‏ ‎‡A Phase II Metabolic Pathways of Spectinamide Antitubercular Agents: A Comparative Study of the Reactivity of 4-Substituted Pyridines to Glutathione Conjugation‏ ‎‡9 1‏
919 ‎‡a potentiationofazoleantifungalsby2adamantanamine‏ ‎‡A Potentiation of azole antifungals by 2-adamantanamine‏ ‎‡9 1‏
919 ‎‡a pterinsulfaconjugatesasdihydropteroatesynthaseinhibitorsandantibacterialagents‏ ‎‡A Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents‏ ‎‡9 1‏
919 ‎‡a quantitativestructureactivityrelationshipstudiesonnitrofuranylantitubercularagents‏ ‎‡A Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents‏ ‎‡9 1‏
919 ‎‡a rapidstructuralcharacterizationofthearabinogalactanandlipoarabinomannaninlivemycobacterialcellsusing2dand3dhrmasnmrstructuralchangesinthearabinanduetoethambutoltreatmentandgenemutationareobserved‏ ‎‡A Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed‏ ‎‡9 1‏
919 ‎‡a relamutantenterococcusfaeciumwithmultiantibiotictolerancearisinginanimmunocompromisedhost‏ ‎‡A RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host‏ ‎‡9 1‏
919 ‎‡a replacingsulfadrugswithnoveldhpsinhibitors‏ ‎‡A Replacing sulfa drugs with novel DHPS inhibitors‏ ‎‡9 1‏
919 ‎‡a reutericyclinandrelatedanalogueskillstationaryphaseclostridiumdifficileatachievablecolonicconcentrations‏ ‎‡A Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations‏ ‎‡9 1‏
919 ‎‡a sb224289antagonizestheantifungalmechanismofthemarinedepsipeptidepapuamidea‏ ‎‡A SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A‏ ‎‡9 1‏
919 ‎‡a screeningalibraryof1600adamantylureasforantimycobacteriumtuberculosisactivityinvitroandforbetterphysicalchemicalpropertiesforbioavailability‏ ‎‡A Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability‏ ‎‡9 1‏
919 ‎‡a solidphasesynthesisandbiologicalevaluationofauridinylbranchedpeptideurealibrary‏ ‎‡A Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library‏ ‎‡9 1‏
919 ‎‡a solidphasesynthesisofathymidinyldipeptideurealibrary‏ ‎‡A Solid-phase synthesis of a thymidinyl dipeptide urea library‏ ‎‡9 1‏
919 ‎‡a spectinamidesanewclassofsemisyntheticantituberculosisagentsthatovercomenativedrugefflux‏ ‎‡A Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux‏ ‎‡9 1‏
919 ‎‡a spectinamidesareeffectivepartneragentsforthetreatmentoftuberculosisinmultiplemouseinfectionmodels‏ ‎‡A Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models‏ ‎‡9 1‏
919 ‎‡a structuralandinvivostudiesontrehalose6phosphatesynthasefrompathogenicfungiprovideinsightsintoitscatalyticmechanismbiologicalnecessityandpotentialfornovelantifungaldrugdesign‏ ‎‡A Structural and In Vivo Studies on Trehalose-6-Phosphate Synthase from Pathogenic Fungi Provide Insights into Its Catalytic Mechanism, Biological Necessity, and Potential for Novel Antifungal Drug Design‏ ‎‡9 1‏
919 ‎‡a structuralbasisforsubstraterecognitionandchemicalinhibitionofoncogenicmageubiquitinligases‏ ‎‡A Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases‏ ‎‡9 1‏
919 ‎‡a structuralcharacterizationofthemycobacteriumtuberculosisbiotinbiosynthesisenzymes78diaminopelargonicacidsynthaseanddethiobiotinsynthetase‏ ‎‡A Structural Characterization of the Mycobacterium tuberculosis Biotin Biosynthesis Enzymes 7,8-Diaminopelargonic Acid Synthase and Dethiobiotin Synthetase,‏ ‎‡9 1‏
919 ‎‡a structuralstudiesofpterinbasedinhibitorsofdihydropteroatesynthase‏ ‎‡A Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase‏ ‎‡9 1‏
919 ‎‡a structureactivityrelationshipsandenzymeinhibitionofpantothenamidetypepantothenatekinaseinhibitors‏ ‎‡A Structure-activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors‏ ‎‡9 1‏
919 ‎‡a structureactivityrelationshipsofspectinamideantituberculosisagentsadissectionofribosomalinhibitionandnativeeffluxavoidancecontributions‏ ‎‡A Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions‏ ‎‡9 1‏
919 ‎‡a structurebaseddesignofnovelpyrimidopyridazinederivativesasdihydropteroatesynthaseinhibitorswithincreasedaffinity‏ ‎‡A Structure-Based Design of Novel Pyrimido[4,5-c]pyridazine Derivatives as Dihydropteroate Synthase Inhibitors with Increased Affinity‏ ‎‡9 1‏
919 ‎‡a structurebaseddesignsynthesisandevaluationof22hydroxyethyl2deoxyadenosineandthe5diphosphatederivativeasribonucleotidereductaseinhibitors‏ ‎‡A Structure-Based Design, Synthesis, and Evaluation of 2′-(2-Hydroxyethyl)-2′-deoxyadenosine and the 5′-Diphosphate Derivative as Ribonucleotide Reductase Inhibitors‏ ‎‡9 1‏
919 ‎‡a synthesesandevaluationofmacrocyclicengelhardioneanalogsasantitubercularandantibacterialagents‏ ‎‡A Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agents‏ ‎‡9 1‏
919 ‎‡a synthesisandevaluationofcyclicsecondaryaminesubstitutedphenylandbenzylnitrofuranylamidesasnovelantituberculosisagents‏ ‎‡A Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents‏ ‎‡9 1‏
919 ‎‡a synthesisandevaluationofestersandcarbamatestoidentifycriticalfunctionalgroupsforesterasespecificmetabolism‏ ‎‡A Synthesis and evaluation of esters and carbamates to identify critical functional groups for esterase-specific metabolism‏ ‎‡9 1‏
919 ‎‡a synthesisandevaluationofnitrofuranylamidesasnovelantituberculosisagents‏ ‎‡A Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents‏ ‎‡9 1‏
919 ‎‡a synthesisandevaluationofpretomanidpa824oxazolidinonehybrids‏ ‎‡A Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids‏ ‎‡9 1‏
919 ‎‡a synthesisandevaluationofthiazolidineamideandnthiazolylamidefluoroquinolonederivatives‏ ‎‡A Synthesis and Evaluation of Thiazolidine Amide and N-Thiazolyl Amide Fluoroquinolone Derivatives.‏ ‎‡9 1‏
919 ‎‡a synthesisandstructureactivityrelationshipofthioacetamidetriazolesagainstescherichiacoli‏ ‎‡A Synthesis and Structure–Activity Relationship of Thioacetamide-Triazoles against Escherichia coli‏ ‎‡9 1‏
919 ‎‡a synthesisandstructureofmycolactoneeisolatedfromfrogmycobacterium‏ ‎‡A Synthesis and structure of mycolactone E isolated from frog mycobacterium‏ ‎‡9 1‏
919 ‎‡a synthesisofbeta500arabinofuranosyl1monophosphorylpolyprenolsexaminationoftheirfunctionasmycobacterialarabinosyltransferasedonors‏ ‎‡A Synthesis of beta-D-arabinofuranosyl-1-monophosphoryl polyprenols: examination of their function as mycobacterial arabinosyl transferase donors.‏ ‎‡9 1‏
919 ‎‡a synthesisofbisubstratestatemimicsofdihydropteroatesynthaseaspotentialinhibitorsandmolecularprobes‏ ‎‡A Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes‏ ‎‡9 1‏
919 ‎‡a synthesisofnewandpotentanaloguesofantituberculosisagent5nitrofuran2carboxylicacid4‏ ‎‡A Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-‏ ‎‡9 1‏
919 ‎‡a synthesisofnewandpotentanaloguesofantituberculosisagent5nitrofuran2carboxylicacid44benzylpiperazin1ylbenzylamidewithimprovedbioavailability‏ ‎‡A Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability‏ ‎‡9 1‏
919 ‎‡a synthesisoptimizationandstructureactivityrelationshipsof35disubstitutedisoxazolinesasnewantituberculosisagents‏ ‎‡A Synthesis, optimization and structure-activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents‏ ‎‡9 1‏
919 ‎‡a synthesisstructureactivityrelationshipstudiesandantibacterialevaluationof4chromanonesandchalconesaswellasolympicinaandderivatives‏ ‎‡A Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives‏ ‎‡9 1‏
919 ‎‡a targetingbacterialmembranefunctionanunderexploitedmechanismfortreatingpersistentinfections‏ ‎‡A Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections‏ ‎‡9 1‏
919 ‎‡a identificationanalysisandstructurebaseddevelopmentofnovelinhibitorsof6hydroxymethyl78dihydropterinpyrophosphokinase‏ ‎‡A The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase‏ ‎‡9 1‏
919 ‎‡a membraneasatargetforcontrollinghypervirulentclostridiumdifficileinfections‏ ‎‡A The membrane as a target for controlling hypervirulent Clostridium difficile infections‏ ‎‡9 1‏
919 ‎‡a structureactivityrelationshipofureaderivativesasantituberculosisagents‏ ‎‡A The structure-activity relationship of urea derivatives as anti-tuberculosis agents‏ ‎‡9 1‏
919 ‎‡a structureofthepantothenatekinaseadppantothenateternarycomplexrevealstherelationshipbetweenthebindingsitesforsubstrateallostericregulatorandantimetabolites‏ ‎‡A The structure of the pantothenate kinase.ADP.pantothenate ternary complex reveals the relationship between the binding sites for substrate, allosteric regulator, and antimetabolites‏ ‎‡9 1‏
919 ‎‡a therapeuticpotentialofthemycobacteriumtuberculosismycolicacidtransportermmpl3‏ ‎‡A Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3‏ ‎‡9 1‏
919 ‎‡a topologyandactivesiteofplsy‏ ‎‡A Topology and Active Site of PlsY‏ ‎‡9 1‏
919 ‎‡a ureadepsipeptidesasclppactivators‏ ‎‡A Ureadepsipeptides as ClpP Activators‏ ‎‡9 1‏
919 ‎‡a validationofmoleculardockingprogramsforvirtualscreeningagainstdihydropteroatesynthase‏ ‎‡A Validation of molecular docking programs for virtual screening against dihydropteroate synthase‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
947 ‎‡a US‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000023471068‏
996 ‎‡2 LC|n 85042235‏
996 ‎‡2 LIH|LNB:B_g__o__d_;=CG‏
996 ‎‡2 ISNI|0000000000830013‏
996 ‎‡2 CAOONL|ncf11324323‏
996 ‎‡2 LC|no2011061474‏
996 ‎‡2 DNB|1157896839‏
996 ‎‡2 ISNI|0000000022371962‏
996 ‎‡2 NUKAT|n 2011108202‏
996 ‎‡2 LC|no2010197687‏
996 ‎‡2 CAOONL|ncf11335371‏
996 ‎‡2 CAOONL|ncf10257099‏
996 ‎‡2 ISNI|0000000115428307‏
996 ‎‡2 CAOONL|ncf11370248‏
996 ‎‡2 LC|no 00043263‏
996 ‎‡2 LC|n 2004011731‏
996 ‎‡2 ISNI|0000000067583221‏
996 ‎‡2 LC|n 88185489‏
996 ‎‡2 ISNI|0000000043190052‏
996 ‎‡2 ISNI|0000000029920901‏
996 ‎‡2 BIBSYS|90217926‏
996 ‎‡2 J9U|987007460307005171‏
996 ‎‡2 DNB|1311083324‏
996 ‎‡2 BIBSYS|8020373‏
996 ‎‡2 J9U|987007389035705171‏
996 ‎‡2 NII|DA10894801‏
996 ‎‡2 BNF|12347122‏
996 ‎‡2 LC|n 84150447‏
996 ‎‡2 DNB|173356214‏
996 ‎‡2 ISNI|0000000108686527‏
996 ‎‡2 LC|n 00097833‏
996 ‎‡2 LC|n 88111956‏
996 ‎‡2 NTA|306972778‏
996 ‎‡2 LC|n 2022065844‏
996 ‎‡2 SUDOC|070347328‏
996 ‎‡2 ISNI|0000000042107448‏
996 ‎‡2 LNB|LNC10-000012365‏
996 ‎‡2 ISNI|0000000491696145‏
996 ‎‡2 J9U|987012329603605171‏
996 ‎‡2 LC|no2011062458‏
996 ‎‡2 LC|no2010176341‏
996 ‎‡2 LIH|LNB:BDJ6;=_q_P‏
996 ‎‡2 SUDOC|172520983‏
996 ‎‡2 DNB|1067795618‏
996 ‎‡2 LC|n 90622043‏
996 ‎‡2 NTA|174340818‏
996 ‎‡2 ISNI|0000000464692579‏
996 ‎‡2 SUDOC|085959715‏
996 ‎‡2 ISNI|0000000493005512‏
996 ‎‡2 LC|no2014036171‏
996 ‎‡2 BNF|16712227‏
996 ‎‡2 SUDOC|279368402‏
996 ‎‡2 BIBSYS|7053903‏
996 ‎‡2 LC|n 88619456‏
996 ‎‡2 NDL|00447197‏
996 ‎‡2 JPG|500280978‏
996 ‎‡2 ISNI|000000003680268X‏
996 ‎‡2 NSK|000209315‏
996 ‎‡2 JPG|500037174‏
996 ‎‡2 DNB|1225575907‏
996 ‎‡2 NTA|342166271‏
996 ‎‡2 NII|DA02305315‏
996 ‎‡2 BIBSYS|90174897‏
996 ‎‡2 B2Q|0000064302‏
996 ‎‡2 LC|n 2001109650‏
996 ‎‡2 SUDOC|116654325‏
996 ‎‡2 LC|n 77001201‏
996 ‎‡2 PLWABN|9810654114105606‏
996 ‎‡2 BLBNB|000341386‏
996 ‎‡2 NLR|RU NLR AUTH 771263‏
996 ‎‡2 SUDOC|171553020‏
996 ‎‡2 ISNI|0000000029927492‏
996 ‎‡2 DNB|1058047027‏
996 ‎‡2 J9U|987012329982505171‏
996 ‎‡2 ISNI|0000000107132434‏
996 ‎‡2 LC|no2014015127‏
996 ‎‡2 DNB|1345684444‏
996 ‎‡2 BIBSYS|90224018‏
996 ‎‡2 ISNI|0000000076283087‏
996 ‎‡2 CAOONL|ncf11222077‏
996 ‎‡2 DNB|143533231‏
996 ‎‡2 DNB|135499291‏
996 ‎‡2 ISNI|0000000055378722‏
996 ‎‡2 BNF|12479623‏
996 ‎‡2 ISNI|0000000066595378‏
996 ‎‡2 DNB|1158034369‏
996 ‎‡2 LC|nb2012002321‏
996 ‎‡2 LC|no2016046677‏
996 ‎‡2 ISNI|0000000385349609‏
996 ‎‡2 ISNI|0000000136073322‏
996 ‎‡2 NTA|086235699‏
996 ‎‡2 NII|DA06775161‏
996 ‎‡2 NII|DA13257713‏
996 ‎‡2 ISNI|000000006674015X‏
996 ‎‡2 CAOONL|ncf10970719‏
996 ‎‡2 ISNI|0000000067869617‏
996 ‎‡2 ISNI|0000000045114651‏
996 ‎‡2 BIBSYS|99057873‏
996 ‎‡2 LC|n 80111613‏
996 ‎‡2 SUDOC|032441851‏
996 ‎‡2 RERO|A000103615‏
996 ‎‡2 LC|n 85020519‏
996 ‎‡2 PLWABN|9810614925505606‏
996 ‎‡2 NKC|jcu2014802131‏
996 ‎‡2 BIBSYS|90528112‏
996 ‎‡2 J9U|987007379315105171‏
996 ‎‡2 DNB|14373198X‏
996 ‎‡2 ISNI|0000000460541511‏
996 ‎‡2 DNB|1157706770‏
996 ‎‡2 LC|n 84111796‏
996 ‎‡2 RERO|A017533835‏
996 ‎‡2 BIBSYS|2003193‏
996 ‎‡2 JPG|500111609‏
996 ‎‡2 LC|n 82125985‏
996 ‎‡2 LC|n 78090953‏
996 ‎‡2 ISNI|0000000075565728‏
996 ‎‡2 JPG|500253245‏
996 ‎‡2 NTA|141934972‏
996 ‎‡2 SUDOC|149474113‏
996 ‎‡2 LC|n 82093298‏
996 ‎‡2 DNB|1155025172‏
996 ‎‡2 BIBSYS|90375609‏
996 ‎‡2 SUDOC|200616013‏
996 ‎‡2 BIBSYS|90589616‏
996 ‎‡2 NTA|381355888‏
996 ‎‡2 J9U|987007316230505171‏
996 ‎‡2 NUKAT|n 2006118869‏
996 ‎‡2 DNB|119451050‏
996 ‎‡2 LC|n 84212495‏
996 ‎‡2 BIBSYS|90271538‏
996 ‎‡2 NTA|148448674‏
996 ‎‡2 DNB|122853393‏
996 ‎‡2 LC|n 81127867‏
996 ‎‡2 LC|n 84087754‏
996 ‎‡2 LC|n 86031023‏
996 ‎‡2 ISNI|0000000039407677‏
996 ‎‡2 ISNI|0000000497037917‏
996 ‎‡2 NLR|RU NLR AUTH 771262‏
996 ‎‡2 BIBSYS|90342269‏
996 ‎‡2 LC|n 79091398‏
996 ‎‡2 DNB|139092226‏
996 ‎‡2 NII|DA10092005‏
996 ‎‡2 BNF|11912066‏
996 ‎‡2 LC|nb2015007301‏
996 ‎‡2 PLWABN|9810539782005606‏
996 ‎‡2 DNB|14322316X‏
996 ‎‡2 BIBSYS|2065405‏
996 ‎‡2 ISNI|0000000051924394‏
996 ‎‡2 ISNI|0000000505716566‏
996 ‎‡2 J9U|987007337315305171‏
996 ‎‡2 NTA|069361967‏
996 ‎‡2 NII|DA05393137‏
996 ‎‡2 ISNI|0000000430976645‏
996 ‎‡2 BIBSYS|4041696‏
996 ‎‡2 CAOONL|ncf12026805‏
996 ‎‡2 BIBSYS|90830379‏
996 ‎‡2 ISNI|0000000497275587‏
996 ‎‡2 NDL|00537740‏
996 ‎‡2 LC|n 92031795‏
996 ‎‡2 RERO|A006291501‏
996 ‎‡2 SUDOC|026978202‏
996 ‎‡2 ISNI|0000000504818173‏
996 ‎‡2 ISNI|0000000030085720‏
996 ‎‡2 LC|n 91116061‏
996 ‎‡2 J9U|987007343469305171‏
996 ‎‡2 LC|n 81030541‏
996 ‎‡2 SUDOC|140465502‏
996 ‎‡2 SUDOC|244875340‏
996 ‎‡2 CAOONL|ncf11220625‏
996 ‎‡2 BNF|15062094‏
996 ‎‡2 CAOONL|ncf10087942‏
996 ‎‡2 NKC|jx20090720004‏
996 ‎‡2 ISNI|0000000051483074‏
996 ‎‡2 NLA|000035297360‏
996 ‎‡2 NUKAT|n 01092785‏
996 ‎‡2 ISNI|0000000063926741‏
996 ‎‡2 DNB|1124081720‏
996 ‎‡2 SUDOC|029275261‏
996 ‎‡2 NUKAT|n 2021125824‏
996 ‎‡2 LC|no2024105193‏
996 ‎‡2 NTA|070653054‏
996 ‎‡2 ISNI|0000000011171033‏
996 ‎‡2 ISNI|0000000045274954‏
996 ‎‡2 LC|n 86109924‏
996 ‎‡2 LC|n 2003104878‏
996 ‎‡2 ISNI|0000000512662359‏
996 ‎‡2 ISNI|0000000084434244‏
996 ‎‡2 CAOONL|ncf10125743‏
996 ‎‡2 J9U|987007588124205171‏
996 ‎‡2 RERO|A023803035‏
996 ‎‡2 ISNI|0000000374307294‏
996 ‎‡2 CAOONL|ncf11880858‏
996 ‎‡2 ISNI|0000000122118075‏
996 ‎‡2 PLWABN|9810640820405606‏
996 ‎‡2 LC|n 99050564‏
996 ‎‡2 ISNI|000000049300531X‏
996 ‎‡2 CAOONL|ncf10348263‏
996 ‎‡2 RERO|A009146821‏
996 ‎‡2 ISNI|0000000495642128‏
996 ‎‡2 B2Q|0001261625‏
996 ‎‡2 ISNI|0000000455321311‏
996 ‎‡2 LIH|LNB:CY_n__p_;=CK‏
996 ‎‡2 ISNI|0000000478942532‏
996 ‎‡2 ISNI|0000000473564202‏
996 ‎‡2 ISNI|0000000108579676‏
996 ‎‡2 EGAXA|vtls001131099‏
996 ‎‡2 NII|DA13982756‏
996 ‎‡2 ISNI|0000000021710635‏
996 ‎‡2 NII|DA01211293‏
996 ‎‡2 LC|n 87926123‏
996 ‎‡2 DBC|87097969571743‏
996 ‎‡2 LC|nb2018011315‏
996 ‎‡2 CAOONL|ncf10293525‏
996 ‎‡2 LC|nr 92035383‏
996 ‎‡2 ISNI|0000000114808324‏
996 ‎‡2 ISNI|0000000367927647‏
996 ‎‡2 BIBSYS|90565378‏
996 ‎‡2 LC|n 2021008736‏
996 ‎‡2 DNB|123079985‏
996 ‎‡2 LC|n 79050920‏
996 ‎‡2 DNB|172220629‏
996 ‎‡2 ISNI|0000000483575570‏
996 ‎‡2 LC|n 85085616‏
996 ‎‡2 BIBSYS|97025375‏
996 ‎‡2 ISNI|0000000509839504‏
996 ‎‡2 LC|n 2020027712‏
996 ‎‡2 BNF|13936579‏
996 ‎‡2 UAE|Mill_a10001750‏
996 ‎‡2 ISNI|0000000032365785‏
996 ‎‡2 SUDOC|129507970‏
996 ‎‡2 LC|n 81101449‏
996 ‎‡2 RERO|A014273031‏
996 ‎‡2 LC|no2015083636‏
996 ‎‡2 NLA|000035297350‏
996 ‎‡2 LC|n 2002063398‏
996 ‎‡2 JPG|500029906‏
996 ‎‡2 NKC|xx0227093‏
996 ‎‡2 LC|no 96006004‏
996 ‎‡2 LC|n 82226796‏
996 ‎‡2 ISNI|0000000480120255‏
996 ‎‡2 BIBSYS|90345169‏
996 ‎‡2 NTA|06828795X‏
996 ‎‡2 ISNI|0000000033520564‏
996 ‎‡2 ISNI|0000000513671222‏
996 ‎‡2 NII|DA05537452‏
996 ‎‡2 RERO|A022809736‏
996 ‎‡2 ISNI|0000000367008210‏
996 ‎‡2 NII|DA00763680‏
996 ‎‡2 ISNI|0000000493194763‏
996 ‎‡2 CYT|AC000006604‏
997 ‎‡a 1900 0 flourished 0000 0‏ ‎‡9 1‏